DocGo (DCGO) Competitors $4.09 -0.09 (-2.15%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends DCGO vs. TNGX, ORGN, AGFS, QSI, LTCH, TDOC, AHCO, VRDN, CDNA, and PNTGShould you be buying DocGo stock or one of its competitors? The main competitors of DocGo include Tango Therapeutics (TNGX), Origin Materials (ORGN), AgroFresh Solutions (AGFS), Quantum-Si (QSI), Latch (LTCH), Teladoc Health (TDOC), AdaptHealth (AHCO), Viridian Therapeutics (VRDN), CareDx (CDNA), and The Pennant Group (PNTG). DocGo vs. Tango Therapeutics Origin Materials AgroFresh Solutions Quantum-Si Latch Teladoc Health AdaptHealth Viridian Therapeutics CareDx The Pennant Group DocGo (NASDAQ:DCGO) and Tango Therapeutics (NASDAQ:TNGX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, community ranking, risk, analyst recommendations, valuation, earnings and institutional ownership. Does the media favor DCGO or TNGX? In the previous week, Tango Therapeutics had 18 more articles in the media than DocGo. MarketBeat recorded 20 mentions for Tango Therapeutics and 2 mentions for DocGo. DocGo's average media sentiment score of 0.56 beat Tango Therapeutics' score of 0.34 indicating that DocGo is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DocGo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tango Therapeutics 4 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts prefer DCGO or TNGX? DocGo presently has a consensus target price of $6.10, suggesting a potential upside of 49.14%. Tango Therapeutics has a consensus target price of $13.14, suggesting a potential upside of 241.37%. Given Tango Therapeutics' higher probable upside, analysts plainly believe Tango Therapeutics is more favorable than DocGo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score DocGo 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Tango Therapeutics 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is DCGO or TNGX more profitable? DocGo has a net margin of 4.35% compared to Tango Therapeutics' net margin of -284.42%. DocGo's return on equity of 8.90% beat Tango Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets DocGo4.35% 8.90% 5.72% Tango Therapeutics -284.42%-49.64%-32.00% Do institutionals & insiders have more ownership in DCGO or TNGX? 56.4% of DocGo shares are owned by institutional investors. Comparatively, 79.0% of Tango Therapeutics shares are owned by institutional investors. 2.7% of DocGo shares are owned by company insiders. Comparatively, 6.3% of Tango Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has more volatility & risk, DCGO or TNGX? DocGo has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, Tango Therapeutics has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Which has preferable valuation and earnings, DCGO or TNGX? DocGo has higher revenue and earnings than Tango Therapeutics. Tango Therapeutics is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDocGo$624.29M0.67$6.86M$0.2814.61Tango Therapeutics$36.53M11.32-$101.74M-$1.18-3.26 Does the MarketBeat Community prefer DCGO or TNGX? DocGo received 17 more outperform votes than Tango Therapeutics when rated by MarketBeat users. Likewise, 74.58% of users gave DocGo an outperform vote while only 72.97% of users gave Tango Therapeutics an outperform vote. CompanyUnderperformOutperformDocGoOutperform Votes4474.58% Underperform Votes1525.42% Tango TherapeuticsOutperform Votes2772.97% Underperform Votes1027.03% SummaryDocGo beats Tango Therapeutics on 11 of the 17 factors compared between the two stocks. Ad Investors AlleyStrange: Why is Amazon suddenly yielding 39.70%?Something big is happening with Amazon stock… While most investors collect ZERO dividends from Amazon… A small group just discovered a "backdoor" way to collect yields up to 39.70%!Click here to see this breakthrough before everyone else → Get DocGo News Delivered to You Automatically Sign up to receive the latest news and ratings for DCGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCGO vs. The Competition Export to ExcelMetricDocGoHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$417.39M$649.49M$5.15B$8.74BDividend YieldN/A1.96%5.18%4.08%P/E Ratio14.6123.6062.6013.00Price / Sales0.674.311,277.9088.72Price / Cash19.2125.4739.7935.27Price / Book1.292.876.455.92Net Income$6.86M-$10.72M$119.73M$225.73M7 Day Performance2.25%-4.03%-5.13%-1.34%1 Month Performance20.65%-1.30%-2.71%1.15%1 Year Performance-29.48%337.04%31.08%24.02% DocGo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCGODocGo2.1711 of 5 stars$4.09-2.2%$6.10+49.1%-30.4%$417.39M$624.29M14.614,164TNGXTango Therapeutics2.0439 of 5 stars$3.35-0.9%N/A-48.7%$359.86M$36.53M-2.8490Analyst RevisionNews CoverageGap UpHigh Trading VolumeORGNOrigin Materials3.4879 of 5 stars$1.25-3.1%N/A+6.9%$182.19M$28.81M-13.89160News CoverageGap UpAGFSAgroFresh SolutionsN/A$3.00flatN/AN/A$161.16M$161.94M-3.19300Analyst ForecastQSIQuantum-Si2.4063 of 5 stars$0.78-22.1%N/A-53.7%$110.37M$1.08M-1.23150Analyst ForecastAnalyst RevisionHigh Trading VolumeLTCHLatchN/A$0.30-3.2%N/A+7.7%$43.09M$48.39M0.00420Gap DownTDOCTeladoc Health3.4792 of 5 stars$9.71-1.1%N/A-45.6%$1.67B$2.59B-1.685,600Analyst ForecastAnalyst RevisionNews CoverageGap UpAHCOAdaptHealth2.1523 of 5 stars$10.69+2.3%N/A+16.4%$1.44B$3.20B-6.4810,700Analyst ForecastVRDNViridian Therapeutics2.4182 of 5 stars$22.43-12.8%N/A+32.5%$1.43B$288,000.00-5.2850Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeCDNACareDx4.0593 of 5 stars$23.32-0.1%N/A+131.9%$1.25B$280.32M-8.64740PNTGThe Pennant Group3.4942 of 5 stars$33.65-0.5%N/A+146.7%$1.16B$544.89M49.495,791Short Interest ↑News Coverage Related Companies and Tools Related Companies TNGX Alternatives ORGN Alternatives AGFS Alternatives QSI Alternatives LTCH Alternatives TDOC Alternatives AHCO Alternatives VRDN Alternatives CDNA Alternatives PNTG Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:DCGO) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DocGo Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DocGo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DCGO Stock Alerts